Heart Failure News and Research RSS Feed - Heart Failure News and Research

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
New evidence-based guidelines for prevention, treatment of POAF

New evidence-based guidelines for prevention, treatment of POAF

The American Association for Thoracic Surgery has released new evidence-based guidelines for the prevention and treatment of perioperative and postoperative atrial fibrillation (POAF) and flutter for thoracic surgical procedures. [More]
Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

More than 4,000 extra wide seats were made to accommodate Brazil's increasing obese population during the World Cup this year. Obesity affects nearly 20 percent of the population in Brazil and is currently classified as a disability. This and other cardiovascular issues, such as the overuse of technology, will be the focus of the Brazilian Congress of Cardiology, a joint event with the European Society of Cardiology and the Brazilian Society of Cardiology, 26-29 September. [More]
Caltech researcher explores link between variable heart rate, health and fitness

Caltech researcher explores link between variable heart rate, health and fitness

Although the heart beats out a very familiar "lub-dub" pattern that speeds up or slows down as our activity increases or decreases, the pattern itself isn't as regular as you might think. In fact, the amount of time between heartbeats can vary even at a "constant" heart rate-and that variability, doctors have found, is a good thing. [More]
Storage symptoms more severe in men with comorbid diabetes

Storage symptoms more severe in men with comorbid diabetes

A study of men with lower urinary tract symptoms and benign prostatic hyperplasia suggests that the presence of comorbid diabetes is associated with more severe urological symptoms. [More]
Medicare experiment shows initial promise

Medicare experiment shows initial promise

Accountable care organizations, an Affordable Care Act model that rewards providers who produce better quality at lower cost, are showing promise in Wisconsin and Iowa. Meanwhile, a top Medicare adviser outlines other needed changes. [More]
NCH advances cardiovascular service line in northwest suburbs

NCH advances cardiovascular service line in northwest suburbs

Northwest Community Healthcare is strengthening cardiovascular care for patients in the northwest suburbs by advancing its cardiovascular service line. NCH has new relationships with cardiothoracic surgeons, vascular surgeons and cardiologists, and, in addition, has announced plans to open a new heart failure clinic this fall in Mount Prospect. [More]
Exercise may have added benefit for cancer patients undergoing chemotherapy: Study

Exercise may have added benefit for cancer patients undergoing chemotherapy: Study

Study after study has proven it true: exercise is good for you. But new research from University of Pennsylvania scientists suggests that exercise may have an added benefit for cancer patients undergoing chemotherapy. [More]
Fast decline in insulin sensitivity seen in pre-diabetic South Asians

Fast decline in insulin sensitivity seen in pre-diabetic South Asians

People of south Asian descent who have Type 2 diabetes show a more rapid decline in fasting glucose levels than White individuals even before they develop the disease, new findings from the Whitehall II study suggest. [More]
‘Reassuring’ findings on microvascular risk in diabetic statin users

‘Reassuring’ findings on microvascular risk in diabetic statin users

Statin treatment prior to diabetes onset does not appear to increase the risk of microvascular disease and may even be protective against some forms, findings from a registry study suggest. [More]
Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen (NASDAQ: AMGN) today announced data from the Phase 3 SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) in Las Vegas. [More]
AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules. [More]
People with diabetes may have six-fold higher risk of developing heart failure

People with diabetes may have six-fold higher risk of developing heart failure

People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests. [More]
Researchers find that people suffering from sleep apnea have weaker brain blood flow

Researchers find that people suffering from sleep apnea have weaker brain blood flow

Employing a measure rarely used in sleep apnea studies, researchers at the UCLA School of Nursing have uncovered evidence of what may be damaging the brain in people with the sleep disorder - weaker brain blood flow. [More]
RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

RT with concurrent chemotherapy post surgery is effective for treating endometrial cancer

Radiation therapy with concurrent paclitaxel chemotherapy following surgery is an effective treatment for patients with high-risk endometrial cancer, according to a study published in the September 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). [More]
Discovery reveals promising target for treatment of end-stage heart failure

Discovery reveals promising target for treatment of end-stage heart failure

As a heart fails, losing its ability to squeeze blood through the circulatory system, the body releases a neurohormone that interferes with the heart's best chance to improve contractility, a team of Temple University School of Medicine researchers show in a study published September 9th in the American Heart Association journal, Circulation. [More]
CareConnectors, VRI develop new software framework to provide mobile health application

CareConnectors, VRI develop new software framework to provide mobile health application

CareConnectors™, developers of the PatientGraph™ Platform and VRI today announced they are developing a new software framework that will provide mobile health application developers with a unified, validated, monitoring data sharing and exchange interface for home telehealth monitoring. [More]
New potential therapeutic targets for treatment of pulmonary arterial hypertension

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago. [More]
New iodine-based contrast material enhances CT images to safely use in most patients

New iodine-based contrast material enhances CT images to safely use in most patients

According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed tomography (CT) images can be safely used in most patients. The study appears online in the journal Radiology. [More]
FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure). [More]
Endo International introduces topical testosterone gel, FORTESTA Gel

Endo International introduces topical testosterone gel, FORTESTA Gel

Endo International plc announced today that it has introduced the first and only generic 2% topical testosterone gel, an authorized generic of FORTESTA® Gel (testosterone gel) CIII. [More]